SIAH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.799600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.463800E-01
Normal-vs-Stage2
5.630400E-01
Normal-vs-Stage3
2.546200E-01
Normal-vs-Stage4
2.140000E-01
Stage1-vs-Stage2
4.022800E-01
Stage1-vs-Stage3
5.500200E-01
Stage1-vs-Stage4
7.095300E-03
Stage2-vs-Stage3
2.151600E-01
Stage2-vs-Stage4
2.595700E-03
Stage3-vs-Stage4
2.239700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.785800E-01
Normal-vs-AfricanAmerican
5.845000E-01
Normal-vs-Asian
4.648000E-01
Caucasian-vs-AfricanAmerican
9.743400E-01
Caucasian-vs-Asian
4.752400E-01
AfricanAmerican-vs-Asian
6.865800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.845200E-01
Normal-vs-Female
5.925600E-01
Male-vs-Female
9.776800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.351200E-01
Normal-vs-Age(41-60Yrs)
8.103000E-01
Normal-vs-Age(61-80Yrs)
5.542000E-01
Normal-vs-Age(81-100Yrs)
1.763570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.137200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.628000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.283000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.648620E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.459700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.089600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.857400E-01
Normal-vs-Daily Drinker
3.432200E-01
Normal-vs-Weekly Drinker
2.968800E-01
Normal-vs-Occasional Drinker
7.409600E-01
Normal-vs-Social Drinker
3.309200E-01
Non Drinker-vs-Daily Drinker
5.387200E-01
Non Drinker-vs-Weekly Drinker
5.267800E-01
Non Drinker-vs-Occasional Drinker
2.308000E-02
Non Drinker-vs-Social Drinker
9.203200E-01
Daily Drinker-vs-Weekly Drinker
9.626600E-01
Daily Drinker-vs-Occasional Drinker
1.982250E-02
Daily Drinker-vs-Social Drinker
4.954800E-01
Weekly Drinker-vs-Occasional Drinker
3.090200E-02
Weekly Drinker-vs-Social Drinker
4.813800E-01
Occasional Drinker-vs-Social Drinker
4.853700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.214250E-01
Normal-vs-Grade 2
2.497200E-03
Normal-vs-Grade 3
5.155700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.984500E-02
Grade 1-vs-Grade 3
7.311700E-02
Grade 1-vs-Grade 4
1.214250E-01
Grade 2-vs-Grade 3
6.558600E-01
Grade 2-vs-Grade 4
2.497200E-03
Grade 3-vs-Grade 4
5.155700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.422400E-01
Normal-vs-NonDiabetic
6.023400E-01
Diabetic-vs-NonDiabetic
2.460200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.895200E-01
Normal-vs-NoPancreatitis
5.423600E-01
Pancreatitis-vs-NoPancreatitis
6.713600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.358400E-01
Normal-vs-N1
6.374200E-01
N0-vs-N1
5.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.608200E-01
Normal-vs-TP53-NonMutant
4.218800E-01
TP53-Mutant-vs-TP53-NonMutant
1.064280E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
